Civic AI
Procurement intelligence
Federal contract award
FY26 UDO INITIATIVE NICHD:R&D: OVAPRENE PHASE 1: PROTOCOL FINALIZATION, REGULATORY APPROVAL, START-UP, AND COMMENCEMENT OF RECRUITMENT, SCREENING, AND ENROLLMENT FOR THE OVAPRENE VAGINAL DEVICE CLINICAL TRIAL (NON-SEVERABLE)
OREGON HEALTH & SCIENCE UNIVERSITY · Department of Health and Human Services
- Value
- $249,678
- Start
- Sep 28, 2023
- End
- May 31, 2025
- Action date
- Feb 23, 2026
- PIID
- 75N94023F00001
- Status
- completed
- NAICS
- 541714 · RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)
- Place of performance
- PORTLAND, OR
- Award type
- DELIVERY ORDER
Description
FY26 UDO INITIATIVE NICHD:R&D: OVAPRENE PHASE 1: PROTOCOL FINALIZATION, REGULATORY APPROVAL, START-UP, AND COMMENCEMENT OF RECRUITMENT, SCREENING, AND ENROLLMENT FOR THE OVAPRENE VAGINAL DEVICE CLINICAL TRIAL (NON-SEVERABLE)
Need modifications, related awards, and vendor peers? Open the full award workspace.